Moreover, genetic variants of PNPLA3 and TM6SF2 are related to NASH and liver cancer but also to triglycerides, LDL cholesterols serum concentrations, and coronary heart disease (11). This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatohepatitis.